IL166239A0 - 2-cyano-4-fluoropyrrolidine derivative or its salt - Google Patents
2-cyano-4-fluoropyrrolidine derivative or its saltInfo
- Publication number
- IL166239A0 IL166239A0 IL16623905A IL16623905A IL166239A0 IL 166239 A0 IL166239 A0 IL 166239A0 IL 16623905 A IL16623905 A IL 16623905A IL 16623905 A IL16623905 A IL 16623905A IL 166239 A0 IL166239 A0 IL 166239A0
- Authority
- IL
- Israel
- Prior art keywords
- cyano
- salt
- fluoropyrrolidine derivative
- fluoropyrrolidine
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002213654 | 2002-07-23 | ||
JP2002264450 | 2002-09-10 | ||
PCT/JP2003/009179 WO2004009544A1 (ja) | 2002-07-23 | 2003-07-18 | 2-シアノ−4−フルオロピロリジン誘導体又はその塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL166239A0 true IL166239A0 (en) | 2006-01-15 |
Family
ID=30772234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16623905A IL166239A0 (en) | 2002-07-23 | 2005-01-11 | 2-cyano-4-fluoropyrrolidine derivative or its salt |
Country Status (18)
Country | Link |
---|---|
US (1) | US7268150B2 (no) |
EP (1) | EP1541551A4 (no) |
JP (1) | JP3778207B2 (no) |
KR (1) | KR100633844B1 (no) |
CN (1) | CN1312127C (no) |
AR (1) | AR040653A1 (no) |
AU (1) | AU2003281625A1 (no) |
BR (1) | BR0312844A (no) |
CA (1) | CA2493339A1 (no) |
IL (1) | IL166239A0 (no) |
MX (1) | MXPA05000896A (no) |
NO (1) | NO20050945L (no) |
NZ (1) | NZ537658A (no) |
PL (1) | PL374854A1 (no) |
RU (1) | RU2288222C2 (no) |
TW (1) | TW200401635A (no) |
WO (1) | WO2004009544A1 (no) |
ZA (1) | ZA200500621B (no) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4357293B2 (ja) * | 2001-06-27 | 2009-11-04 | スミスクライン ビーチャム コーポレーション | ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類 |
HUP0200849A2 (hu) * | 2002-03-06 | 2004-08-30 | Sanofi-Synthelabo | N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra |
TW200528440A (en) * | 2003-10-31 | 2005-09-01 | Fujisawa Pharmaceutical Co | 2-cyanopyrrolidinecarboxamide compound |
ES2375625T3 (es) * | 2004-02-05 | 2012-03-02 | Kyorin Pharmaceutical Co., Ltd. | Derivados de biciclo éster. |
CN1922139B (zh) * | 2004-02-18 | 2010-12-29 | 杏林制药株式会社 | 双环酰胺衍生物 |
US7514571B2 (en) * | 2004-02-27 | 2009-04-07 | Kyorin Pharmaceutical Co., Ltd. | Bicyclo derivative |
TW200604167A (en) * | 2004-04-27 | 2006-02-01 | Astellas Pharma Inc | Pyrrolidine derivatives |
WO2006012395A2 (en) | 2004-07-23 | 2006-02-02 | Susan Marie Royalty | Peptidase inhibitors |
TW200630337A (en) * | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
JP2008019168A (ja) * | 2004-10-22 | 2008-01-31 | Astellas Pharma Inc | 2−シアノ−4−フルオロピロリジン誘導体の製造法 |
CA2587749A1 (en) * | 2004-12-08 | 2006-06-15 | Astellas Pharma Inc. | Piperidine derivative and process for producing the same |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
JP2008024592A (ja) * | 2005-01-28 | 2008-02-07 | Taisho Pharmaceut Co Ltd | シアノピロリジン誘導体含有固形製剤用組成物、それを含有する固形製剤及びその製造方法 |
AP2007004234A0 (en) | 2005-04-22 | 2007-12-31 | Alantos Pharm Holding | Dipeptidyl peptidase-IV inhibitors |
US20080300251A1 (en) * | 2005-09-05 | 2008-12-04 | Sattigeri Jitendra A | Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors |
ATE482947T1 (de) * | 2005-12-21 | 2010-10-15 | Hoffmann La Roche | Neues salz und polymorph des dpp-iv-hemmers |
US20090156465A1 (en) | 2005-12-30 | 2009-06-18 | Sattigeri Jitendra A | Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
AU2007224066B2 (en) | 2006-03-08 | 2011-10-27 | Kyorin Pharmaceutical Co., Ltd. | Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof |
US8247442B2 (en) * | 2006-03-29 | 2012-08-21 | Purdue Pharma L.P. | Benzenesulfonamide compounds and their use |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
US8937181B2 (en) * | 2006-04-13 | 2015-01-20 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
WO2007118853A1 (en) * | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
US7727978B2 (en) * | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
CN101230058A (zh) * | 2007-01-23 | 2008-07-30 | 上海恒瑞医药有限公司 | 双环氮杂烷类衍生物、其制备方法及其在医药上的用途 |
WO2008114857A1 (ja) | 2007-03-22 | 2008-09-25 | Kyorin Pharmaceutical Co., Ltd. | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
CN103330939A (zh) | 2007-04-03 | 2013-10-02 | 田边三菱制药株式会社 | 二肽基肽酶iv抑制化合物和甜味剂的并用 |
US8399486B2 (en) | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
US8338450B2 (en) * | 2007-09-21 | 2012-12-25 | Lupin Limited | Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors |
WO2009040659A2 (en) * | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
JP2011509289A (ja) * | 2008-01-10 | 2011-03-24 | サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド | 新規なアシルシアノピロリジン誘導体 |
CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
MX2010008049A (es) * | 2008-01-23 | 2010-11-12 | Jiangsu Hansoh Pharmaceutical Co Ltd | Derivados de dicicloazaalcano, sus procesos de preparacion y usos medicos. |
EP2146210A1 (en) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
WO2010016584A1 (ja) * | 2008-08-07 | 2010-02-11 | 杏林製薬株式会社 | ビシクロ[2.2.2]オクチルアミン誘導体の製造方法 |
US20110152342A1 (en) * | 2008-08-14 | 2011-06-23 | Hiroshi Uchida | Stabilized pharmaceutical composition |
US8748457B2 (en) | 2009-06-18 | 2014-06-10 | Lupin Limited | 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
CN102918027A (zh) | 2010-04-06 | 2013-02-06 | 艾尼纳制药公司 | Gpr119受体调节剂和对与所述受体有关的障碍的治疗 |
JP5684895B2 (ja) * | 2010-04-20 | 2015-03-18 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | ピラゾールカルボン酸アミドの調製方法 |
US10894787B2 (en) | 2010-09-22 | 2021-01-19 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US20140051714A1 (en) | 2011-04-22 | 2014-02-20 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
US20140038889A1 (en) | 2011-04-22 | 2014-02-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
RU2485952C2 (ru) * | 2011-08-18 | 2013-06-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Ингибирующее дипептидилпептидазу iv средство и фармацевтическая композиция на его основе |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
CN103788070B (zh) * | 2012-10-26 | 2017-10-20 | 南京华威医药科技开发有限公司 | Dpp‑4抑制剂类多聚物 |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
CN105985357A (zh) * | 2015-02-12 | 2016-10-05 | 北京赛林泰医药技术有限公司 | 取代的氨基六元饱和杂脂环类长效dpp-iv抑制剂 |
US10555929B2 (en) | 2015-03-09 | 2020-02-11 | Coherus Biosciences, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
WO2018187350A1 (en) | 2017-04-03 | 2018-10-11 | Coherus Biosciences Inc. | PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
WO2001055105A1 (en) | 2000-01-24 | 2001-08-02 | Novo Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
TW583185B (en) | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
TWI290919B (en) | 2000-10-06 | 2007-12-11 | Tanabe Seiyaku Co | Nitrogen-containing five-membered ring compound, a pharmacologically permissible salt thereof and the method for producing the same |
TWI243162B (en) | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
US7074817B2 (en) | 2001-06-20 | 2006-07-11 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
GB0115517D0 (en) | 2001-06-25 | 2001-08-15 | Ferring Bv | Novel antidiabetic agents |
JP4357293B2 (ja) * | 2001-06-27 | 2009-11-04 | スミスクライン ビーチャム コーポレーション | ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類 |
HUP0200849A2 (hu) * | 2002-03-06 | 2004-08-30 | Sanofi-Synthelabo | N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra |
-
2003
- 2003-06-27 TW TW092117723A patent/TW200401635A/zh unknown
- 2003-07-18 RU RU2005101426/04A patent/RU2288222C2/ru not_active IP Right Cessation
- 2003-07-18 WO PCT/JP2003/009179 patent/WO2004009544A1/ja not_active Application Discontinuation
- 2003-07-18 CA CA002493339A patent/CA2493339A1/en not_active Abandoned
- 2003-07-18 MX MXPA05000896A patent/MXPA05000896A/es not_active Application Discontinuation
- 2003-07-18 CN CNB03815854XA patent/CN1312127C/zh not_active Expired - Fee Related
- 2003-07-18 BR BR0312844-0A patent/BR0312844A/pt not_active IP Right Cessation
- 2003-07-18 EP EP03741499A patent/EP1541551A4/en not_active Withdrawn
- 2003-07-18 NZ NZ537658A patent/NZ537658A/en unknown
- 2003-07-18 US US10/492,347 patent/US7268150B2/en not_active Expired - Fee Related
- 2003-07-18 JP JP2004522764A patent/JP3778207B2/ja not_active Expired - Fee Related
- 2003-07-18 KR KR1020057001166A patent/KR100633844B1/ko not_active IP Right Cessation
- 2003-07-18 AU AU2003281625A patent/AU2003281625A1/en not_active Abandoned
- 2003-07-18 PL PL03374854A patent/PL374854A1/xx not_active Application Discontinuation
- 2003-07-22 AR AR20030102623A patent/AR040653A1/es not_active Application Discontinuation
-
2005
- 2005-01-11 IL IL16623905A patent/IL166239A0/xx unknown
- 2005-01-21 ZA ZA200500621A patent/ZA200500621B/xx unknown
- 2005-02-22 NO NO20050945A patent/NO20050945L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1312127C (zh) | 2007-04-25 |
US7268150B2 (en) | 2007-09-11 |
KR20050023452A (ko) | 2005-03-09 |
TW200401635A (en) | 2004-02-01 |
CN1665785A (zh) | 2005-09-07 |
BR0312844A (pt) | 2005-04-26 |
US20050176771A1 (en) | 2005-08-11 |
RU2005101426A (ru) | 2005-07-20 |
CA2493339A1 (en) | 2004-01-29 |
ZA200500621B (en) | 2006-07-26 |
PL374854A1 (en) | 2005-11-14 |
KR100633844B1 (ko) | 2006-10-16 |
EP1541551A8 (en) | 2005-11-09 |
MXPA05000896A (es) | 2005-04-19 |
NO20050945L (no) | 2005-04-22 |
RU2288222C2 (ru) | 2006-11-27 |
NZ537658A (en) | 2006-08-31 |
JP3778207B2 (ja) | 2006-05-24 |
AU2003281625A1 (en) | 2004-02-09 |
EP1541551A4 (en) | 2007-01-24 |
EP1541551A1 (en) | 2005-06-15 |
JPWO2004009544A1 (ja) | 2005-11-17 |
WO2004009544A1 (ja) | 2004-01-29 |
AR040653A1 (es) | 2005-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1900052I1 (hu) | 2-acilaminotiazol-származékok vagy sóik | |
IL166239A0 (en) | 2-cyano-4-fluoropyrrolidine derivative or its salt | |
PL1632477T3 (pl) | Pochodna benzamidu lub jej sól | |
AP1850A (en) | Spiroindolineplperidine derivatives | |
EG24050A (en) | Heterocylocarboxamide derivatives | |
AP2005003343A0 (en) | Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors | |
HK1077068A1 (en) | Azolidinone-vinyl fused-benzene derivatives | |
IL166121A0 (en) | Indole-3-sulphur derivatives | |
EP1522540A4 (en) | AZAARENE DERIVATIVES | |
HK1088602A1 (en) | 2-pyridinecarboxamide derivatives | |
HK1088326A1 (en) | Piperidine-benzenesulfonamide derivatives | |
PL376475A1 (en) | N-substituted-2-oxodihydropyridine derivatives | |
ZA200500471B (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
HK1089443A1 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
GB0317665D0 (en) | Qinazoline derivatives | |
AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
AU2003244181A1 (en) | Phenoxypyridine derivative or salt thereof | |
EP1531854A4 (en) | O-DERIVATED NOCATHIACIN DERIVATIVES | |
GB0319793D0 (en) | Pyridinylmorpholine derivatives | |
GB0213488D0 (en) | 2-Naphthamide derivatives | |
AU2003243397A8 (en) | Homo-camptothecin derivatives | |
GB0207286D0 (en) | Salt | |
AU2003201887A1 (en) | 2-acylaminothiazole derivative or salt thereof | |
GB0206255D0 (en) | Novel salt forms | |
HK1081943A1 (en) | N-hydroxyformamidine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of name of proprietor(s) |